Intelligent Bio Solutions INBS
NASDAQ INBS
$2.61 -0.04 (-1.51%)
As of: Aug 21, 2026 · 10:52 AM EDT

Intelligent Bio Solutions Inc. (INBS) Total Debt (2020 - 2024)

Intelligent Bio Solutions (INBS) posted quarterly Total Debt of $150426.0 for Q1 2024, down 68.05% year-over-year from $470872.0 in Q2 2023, and down 34.87% quarter-over-quarter from $230969.0 in Q4 2023.

Intelligent Bio Solutions Inc. (INBS) Total Debt (2020 - 2024) Analysis & Trends

Intelligent Bio Solutions' Total Debt history runs 5 years deep, the most recent figure standing at $150426.0 for Q1 2024.

  • In Q1 2024, Total Debt fell 68.05% year-over-year to $150426.0; the TTM figure through Mar 2024 stood at $150426.0 (down 68.05% YoY), while the FY2023 annual figure was $402862.0, down 85.8% from the prior year.
  • Total Debt for Q1 2024 stood at $150426.0, down from $230969.0 in the prior quarter.
  • The five-year high for Total Debt was $2.8 million in Q2 2022, with the low at $9536.0 in Q4 2021.
  • The 5-year median for Total Debt is $354548.0 (2023), against an average of $589577.3.
  • The sharpest annual moves came in 2021 and 2022: Total Debt sank 99.25% in 2021, then jumped 21190.87% in 2022.
  • Intelligent Bio Solutions' Total Debt stood at $431621.0 in 2020, then plunged by 97.79% to $9536.0 in 2021, then surged by 5220.92% to $507403.0 in 2022, then tumbled by 54.48% to $230969.0 in 2023, then sank by 34.87% to $150426.0 in 2024.
  • Business Quant data shows INBS's Total Debt at $150426.0 in Q1 2024, $230969.0 in Q4 2023, and $306234.0 in Q3 2023.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2024 150,426.00
Dec 31, 2023 230,969.00
Sep 30, 2023 306,234.00
Jun 30, 2023 402,862.00
Mar 31, 2023 470,872.00
Dec 31, 2022 507,403.00
Sep 30, 2022 1.02 Mn
Jun 30, 2022 2.84 Mn
Dec 31, 2021 9,536.00
Sep 30, 2021 68,808.00
Jun 30, 2021 13,323.00
Mar 31, 2021 37,235.00
Dec 31, 2020 431,621.00
Jun 30, 2020 1.77 Mn